HAIR REGROWTH TREATMENT minoxidil 5 g/100mL Solution
by Amazon.com Services LLC · 6 BOTTLE in 1 CARTON (72288-667-40) / 60 mL in 1 BOTTLE (72288-667-00)
NDC 72288-0667-40
🏷️ FDA NDC (as labeled)
72288-667-40
billing pads the product segment with a zero
OTC
Generic
On market
Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
72288-667-40
Product NDC
72288-667
11-digit billing NDC
72288066740
UNII
5965120SH1
Application #
ANDA075598
SPL Set ID
0ce77e6b-c4cf-49e2-8fd9-183286c26f8a
Established class (EPC)
Arteriolar Vasodilator
Physiologic effect
Arteriolar Vasodilation
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2026-09-03
Route
TOPICAL
Dosage form
SOLUTION
Substance
MINOXIDIL
Why two NDCs?
The FDA registers this code as 72288-667-40 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72288-0667-40. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerAmazon.com Services LLC
Application holderL PERRIGO CO
FDA applicationANDA075598 (ANDA)
Labeler code72288
First marketedSep 2026
Product typeHuman Otc Drug
Portfolio335 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- That's a really common question. Minoxidil tablets are very effective at lowering blood pressure, but they cause two side effects that need to be managed: your heart speeds up, and...
- I've been prescribed minoxidil tablets for blood pressure — why do I need to take other pills with it?
- It takes patience — most people need at least 2 to 4 months of twice-daily use before they notice any regrowth. Some products note that results can start appearing around the 2-mon...
- I'm using a topical minoxidil solution for hair loss. How long before I see results?
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Minoxidil — tap one for details:
1
Nutrient depletion considerations
Minoxidil may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about minoxidil?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
3 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesalcohol, propylene glycol, purified water
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| equate hair regrowth treatment 5 g/100mL 49035-0746-16 | Wal-Mart | 1 bottle | — | — | FDA listed | — |
| Elevate Hair Growth Serum 5 g/100mL 81653-0010-01 | Guangzhou | 60 ml | — | — | FDA listed | — |
| Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0024-01 | Shenzhen | 60 ml | — | — | FDA listed | — |
| Hair regrowth treatment 5 g/100mL 81653-0005-01 | Guangzhou | 3 bottles | — | — | FDA listed | — |
| Minoxidil Hair Growth Serum 5 g/100mL 85092-0001-01 | Shenzhen | 1 bottle | — | — | Discontinued | — |
| 5% MINOXIDIL TOPICAL Solution 5 g/100mL 85174-0001-02 | Nanhong | 2 bottles | — | — | Discontinued | — |
| 5% Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0023-01 | Shenzhen | 60 ml | — | — | FDA listed | — |
| Leader Minoxidil 5 g/100mL 70000-0653-01 | Cardinal | 3 bottles | — | — | FDA listed | — |
| hims hair regrowth treatment 5 g/100mL 71730-0000-16 | Hims | 1 bottle | — | — | FDA listed | — |
| Hair Beardgrowth Foam 5 g/100mL 85173-0001-01 | Shenzhen | 60 ml | — | — | FDA listed | — |
| Good Sense Hair Regrowth Treatment 5 g/100mL 00113-1032-30 | L. | 3 bottles | — | — | FDA listed | — |
| hair regrowth treatment 5 g/100mL 00363-0032-16 | Walgreen | 1 bottle | — | — | FDA listed | — |
| equate hair regrowth treatment 5 g/100mL 79903-0222-01 | WALMART | 1 bottle | — | — | FDA listed | — |
| minoxidil 5 g/100mL 56062-0322-16 | Publix | 1 bottle | — | — | FDA listed | — |
| hair regrowth treatment 5 g/100mL 41250-0428-30 | Meijer, | 3 bottles | — | — | FDA listed | — |
| kirkland signature minoxidil 5 g/100mL 63981-0032-40 | Costco | 6 bottles | — | — | FDA listed | — |
| hair regrowth treatment 5 g/100mL 11822-1260-00 | Rite | 1 bottle | — | — | FDA listed | — |
| hair regrowth treatment 5 g/100mL 30142-0632-30 | Kroger | 3 bottles | — | — | FDA listed | — |
| Soti Hair Growth Serum 5 g/100mL 81653-0013-01 | Guangzhou | 60 ml | — | — | FDA listed | — |
| minoxidil 5 g/100mL 37808-0833-16 | H | 1 bottle | — | — | FDA listed | — |
| members mark hair regrowth treatment 5 g/100mL 68196-0032-40 | Sam's | 6 bottles | — | — | FDA listed | — |
| OLIVITA Minoxidil 5 g/100mL 83818-0031-01 | Shenzhen | 60 ml | — | — | FDA listed | — |
| Hair Regen Hair Growth Treatment 5 g/100mL 84232-0001-01 | YIWUYIZHOUTRADINGCO.,LTD | 60 ml | — | — | FDA listed | — |
| Minoxidil Hair Growth Serum 5 g/100mL 85741-0004-01 | Shenzhen | 1 bottle | — | — | FDA listed | — |
| hair regrowth treatment 5 g/100mL 21130-0611-16 | Safeway | 1 bottle | — | — | FDA listed | — |
| signature care hair regrowth treatment 5 g/100mL 21130-0819-16 | Safeway | 1 bottle | — | — | Discontinued | — |
| minoxidil 5 g/100mL 71713-0094-16 | THIRTY | 1 bottle | — | — | FDA listed | — |
| Minoxidil Extra Strength for Men 5 g/100mL 72484-0095-03 | Roman | 1 bottle | — | — | FDA listed | — |
| VENANOCI Minoxidil 5 g/100mL 83818-0029-01 | Shenzhen | 60 ml | — | — | FDA listed | — |
| Hair-Regen Hair Growth Treatment 5 g/100mL 84232-0011-26 | Yiwu | 6 bottles | — | — | FDA listed | — |
| Hair Growth Serum Roll-ON 5 g/100mL 85524-2625-02 | FlexiGo | 1 bottle | — | — | FDA listed | — |
| LILIVERA Hair Regrowth Kit 5 g/100mL 60771-0012-01 | Guangzhou | 60 ml | — | — | FDA listed | — |
| basic care hair regrowth treatment 5 g/100mL 72288-0798-16 | Amazon.com | 60 ml | — | — | FDA listed | — |
| up and up hair regrowth treatment for men 5 g/100mL 11673-0317-30 | Target | 3 bottles | — | — | FDA listed | — |
| Psalmonica Hair Growth Serum 5 g/100mL 60771-0013-01 | Guangzhou | 60 ml | — | — | FDA listed | — |
| Hair Regrowth Treatment 5 g/100mL 69842-0598-16 | CVS | 1 bottle | — | — | FDA listed | — |
| 5%Minoxidil Hair Growth Serum 5 g/100mL 84355-0003-01 | Guangzhou | 1 bottle | — | — | FDA listed | — |
| 5%Minoxidil Hair Growth Sprays Serum 5 g/100mL 84355-0004-01 | Guangzhou | 1 bottle | — | — | FDA listed | — |
| Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0031-01 | Shenzhen | 100 ml | — | — | FDA listed | — |
| Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0032-01 | Shenzhen | 60 ml | — | — | FDA listed | — |
| Minoxidil Hair Regrowth Treatment 5 g/100mL 85636-0033-01 | Shenzhen | 100 ml | — | — | FDA listed | — |
| ValBello 5 g/100mL 87942-0001-01 | ValBello | 125 ml | — | — | FDA listed | — |
| Hair Regrowth Treatment 5 g/100mLthis 72288-0667-40 | Amazon.com | 6 bottles | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2026
On the market since
Sep 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Minoxidil (matched by generic name) — the program that covers self-administered drugs. 3 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Minoxidil. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.5M
Claims incl. refills
260.9K
Beneficiaries
202.1K
Spend / beneficiary
$17.33
Spend / claim
$13.42
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for hair regrowth treatment (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 77%
Female · 23%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 72288-0667-40 You're viewing this | 6 BOTTLE in 1 CARTON (72288-667-40) / 60 mL in 1 BOTTLE (72288-667-00) | 2026-09-03 | Active |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 72288-667-40, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 72288-0667-40, written without dashes as 72288066740. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 72288-0667-40, the first segment (72288) is the labeler code FDA assigned to Amazon.com Services LLC; the middle segment (0667) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (40) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Amazon.com Services LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Amazon.com Services LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Use to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)
⏱️ Dosage and Administration ▾
Directions • apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area • using more or more often will not improve results • continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again
⚠️ Warnings ▾
Warnings For external use only. For use by men only. Flammable: Keep away from fire or flame Do not use if • you are a woman • your amount of hair loss is different than that shown on the side of this carton or your hair loss is on the front of the scalp.
Minoxidil topical solution 5% is not intended for frontal baldness or receding hairline. • you have no family history of hair loss • your hair loss is sudden and/or patchy • you do not know the reason for your hair loss • you are under 18 years of age. Do not use on babies and children. • your scalp is red, inflamed, infected, irritated, or painful • you use other medicines on the scalp Ask a doctor before use if you have heart disease When using this product • do not apply on other parts of the body • avoid contact with the eyes.
In case of accidental contact, rinse eyes with large amounts of cool tap water. • some people have experienced changes in hair color and/or texture • it takes time to regrow hair. Results may occur at 2 months with twice a day usage. For some men, you may need to use this product for at least 4 months before you see results. • the amount of hair regrowth is different for each person.
This product will not work for all men. Stop use and ask a doctor if • chest pain, rapid heartbeat, faintness, or dizziness occurs • sudden, unexplained weight gain occurs • your hands or feet swell • scalp irritation or redness occurs • unwanted facial hair growth occurs • you do not see hair regrowth in 4 months May be harmful if used when pregnant or breast-feeding. Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
📦 Storage and Handling ▾
Other information • see hair loss pictures on side of this carton • before use, read all information on carton and enclosed leaflet • keep the carton. It contains important information. • hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with minoxidil topical solution 5% for men • in clinical studies with mostly white men aged 18-49 years with moderate degrees of hair loss, minoxidil topical solution 5% for men provided more hair regrowth than minoxidil topical solution 2% • store at 20° to 25°C (68° to 77°F).
Keep tightly closed.
🧪 Active Ingredient ▾
Active ingredient Minoxidil 5% w/v
🧪 Inactive Ingredients ▾
Inactive ingredients alcohol, propylene glycol, purified water
🎯 Purpose ▾
Purpose Hair regrowth treatment for men
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.